Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation.
about
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipientsPre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipientsUpdate on human herpesvirus 6 biology, clinical features, and therapyOral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts.Human cytomegalovirus terminase as a target for antiviral chemotherapy.Tomorrow's challenges for herpesvirus management: potential applications of valacyclovir.Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxisCanadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report.Acceleration of allograft failure by cytomegalovirusLeflunomide for cytomegalovirus: bench to bedside.Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience.Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation.Ganciclovir-resistant cytomegalovirus in organ transplant recipients.Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial.Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis.Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients.Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation
P2860
Q24200991-5BC76C20-B201-4F18-B35F-1FDD1B4C10E6Q24244606-3B4413E3-73B4-4EA5-B919-7D93195456D3Q24557543-5BD739B7-CB8F-4FCF-A3D8-9B65D466AF56Q34481742-4D11088E-D6A5-4473-B314-AADB7E41D6CBQ34580776-2695C392-47C9-4C5D-8D3F-4C94B4EA81B5Q34918468-6F8E71DC-E48E-423A-8708-98645AB85961Q35914030-AE085A07-AA59-4603-B740-FB92C056E92AQ36006091-E8BE1096-5932-4558-B5E2-DB2B0B8DFE6EQ36433529-4128873B-2934-460E-B849-EA13014A606DQ37957446-1C78A377-191A-429C-9491-30BE24204ED4Q39502888-BF028E6B-AFA6-46D7-B514-396545EC0A0FQ40115981-86A79552-1DCC-4EB9-BC7C-25A3D93C796FQ44000196-51A8A464-656A-4FB3-B4A2-C34ECC001661Q44407642-CD50FBA4-3859-4A86-9DF4-762096EFE150Q44461493-5EFD84A0-572D-47F5-B922-8A0CA98197F5Q46963345-24DF6121-D508-4C05-BC4C-70B2C880D03BQ58075077-9E99B36B-5B96-46CB-A0E7-88E2C40C6AC5
P2860
Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Prophylaxis for CMV should now ...... n solid organ transplantation.
@ast
Prophylaxis for CMV should now ...... n solid organ transplantation.
@en
Prophylaxis for CMV should now ...... n solid organ transplantation.
@nl
type
label
Prophylaxis for CMV should now ...... n solid organ transplantation.
@ast
Prophylaxis for CMV should now ...... n solid organ transplantation.
@en
Prophylaxis for CMV should now ...... n solid organ transplantation.
@nl
prefLabel
Prophylaxis for CMV should now ...... n solid organ transplantation.
@ast
Prophylaxis for CMV should now ...... n solid organ transplantation.
@en
Prophylaxis for CMV should now ...... n solid organ transplantation.
@nl
P2860
P356
P1476
Prophylaxis for CMV should now ...... n solid organ transplantation.
@en
P2860
P356
10.1002/RMV.309
P577
2001-03-01T00:00:00Z